l-carnitine tmao koeth 2013 nature medicine γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of to Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis:
Gut Metabolite Trimethylamine N Oxide in Atherosclerosis: From Mechanism to Therapy Frontiers Gut Microbiota Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? Effects of choline metabolitetrimethylamine N oxide on immunometabolism in inflammatory bowel disease Frontiers L Carnitine intake and high trimethylamine N oxide plasma levels correlate with low aortic lesions in ApoE transgenic mice expressing CETP ScienceDirect A Multi omic Association Study of Trimethylamine N Oxide ScienceDirect
Pay in 4 interest-free payments of $6.02 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




